A Phase II Prospective Trial of Photobiomodulation in Limiting Oral Mucositis in the Treatment of Locally Advanced Head and Neck Cancer Patients

This study compares historical rates of grade 3+ OM (35-40%) in HNC patients undergoing definitive concurrent CRT versus our cohort of patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated with prophylactic PBM.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Toxicity, Quality of Life, Survivorship, Costs of Care Source Type: research